1. Home
  2. >>Scrip
  3. >>Business
  4. >>Deals
  5. >>Deal Watch

Deal Watch

Deal Watch: Renexxion To Go Public While Avid Biosciences Goes Private

 
• By Joseph Haas

Plus deals involving Synaffix/BigHat, AbbVie/EvolveImmune, Servier/Aitia, Dr. Falk/Kynos, Bayer/Dewpoint and more.

Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini

 
• By Joseph Haas, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Plus deal news involving LianBio/NImmune, REGiMMUNE/Kiji, Chengdu Baiyu/Novartis, Orasis/Optus, Takeda/Wave Life Sciences, Ono/LigaChem, Alchem/Sonnet, Astellas/AviadoBio, Innovent/Ask Pharm and Dr Reddy’s/Gilead.

Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline

 
• By Joseph Haas

Lilly unit explores external innovation with insitro and Qinotto, plus deals involving Novartis/3BP, Eterna/Factor, Molecure/Ocean, Bayer/MOMA, Virios/Wex and more.

Deal Watch: Shionogi Will Market Nxera’s Insomnia Drug In Japan

 
• By Joseph Haas, Lisa Takagi, Vibha Ravi, and Dexter Jie Yan

Plus deals involving Jiangsu Alphamab/CSPC, Zydus/CDRI, Junshi/JSIAMA, Repair/Genevant, Sanofi/I-Mab, Novartis/Mitem and BioAtla/Context.

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Plus deals involving AbbVie/Ripple, Novo Nordisk/Korro Bio, Novo Nordisk/NanoVation, Bharat, Alopexx, Gilead/Genesis, Lilly/Genetic Leap, Contraline/Population Council, Proveca/Cessatech, Vivtex/Equillium and more.

Asia Deal Watch: EpimAb Licenses Bispecific Antibody To Newly Formed Vignette

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Lisa Takagi

Also including deals between EpimAb/Vignette, Allist/Jacobio, Rigel/Kissei, Simcere/TargetRx, Altamira/Nuance, PharmaEssentia/Forus and Chugai/LTL.

Deal Watch: Lilly Turns To Oblique For Antibody Discovery

 
• By Joseph Haas

Plus deals involving Lilly/Oblique, Rafael Holdings/Cyclo, ADCendo/Multitude, Ocuvex/Visiox and more.

Deal Watch: Revance To Go Private In Crown Laboratories Buyout

 
• By Joseph Haas and Vibha Ravi

Plus deals involving AstraZeneca/Conduit, Recursion/Exscientia, G1/Pharmacosmos, Sanofi/Vir, Passage Bio/GEMMA and Lupin/Evofem. Also including deals in brief.

Asia Deal Watch: Ocumension Obtains Chinese Rights To Eight Alcon Products

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, and Anju Ghangurde

Also deals involving WuXi/Medigene, Eisai/Seed, Genor/Two River/Third Rock Ventures, ImmuneOnco/Instil, Biocytogen/Ideaya, Takeda/Dr Reddy’s/Zydus/Mankind and deals in brief.

Deal Watch: BI Acquires Nerio For Novel Immune Checkpoint Inhibitor

 
• By Joseph Haas and Mary Jo Laffler

Featuring deals involving Novartis/Dren, Palvella/Pieris, Eyenovia/Senju, Addex/Johnson & Johnson, Agilent/BioVectra, Meitheal/Nabriva, plus tech transfer agreements and deals in brief.

Asia Deal Watch: Orum, Vertex Team Up On Gene Editing Conditioning Agents

 
• By Joseph Haas, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Plus deals involving Eisai/Sato, Keymed/Belenos, Taiho/Arcus, IASO/Innovent, Biocytogen/SOTIO, Ensol/Spine, TMS/Hokkaido University and Yuhan/Ubix.

Deal Watch: AbbVie Offloads Three Cystic Fibrosis Candidates To Sionna

 
• By Joseph Haas

Plus deals involving Abeona/Beacon, TuHura/Kintara, Crosswalk/Codexis, Lantheus/Life Molecular Imaging as well as tech transfer agreements and small deals involving Pfizer, Sanofi and Ipsen.

Asia Deal Watch: ProGen To Partner With Rani On GLP-2 Agonist In Obesity

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Healios/Astellas Institute for Regenerative Medicine, Otsuka/Ionis, IMBiologics/Navigator and more.

Deal Watch: Lilly Partners With OpenAI On Drug-Resistant Pathogens

 
• By Joseph Haas

Plus transactions involving ANI/Alimera, Gilead/ashibio, Sanofi/Belharra and more.

Asia Deal Watch: Chugai Extends Relationship With Helsinn

 
• By Joseph Haas, Vibha Ravi, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Plus deals involving Kissei/JWP, Shionogi/Cilcare, Takeda/Torrent, Genome & Co./Debiopharm, Kaken/J&J, CStone/Ewopharma, MediLink/BioNTech and more.

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

 
• By Joseph Haas

Plus deals involving GSK/Elsie, Lilly/QurAlis, Gilead/Cartography as well as tech transfer announcements and deals in brief.

Deal Watch: Merck KGaA Enhances Cell/Gene Therapy Capabilities With Mirus Takeout

 
• By Joseph Haas, Vibha Ravi, and Dexter Jie Yan

Plus deals involving Immunis/Toray, AstraZeneca/Nona, Swixx/Biopas, Deimos/G1, Serum Institute of India/IntegriMedical/ImmunityBio plus tech transfer agreements and deals in brief.

Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Plus transactions involving Sanofi/Fulcrum, Reneo/OnKure, Lilly/Mitsubishi Tanabe, Lantern/Oregon, Zydus/Eiger and more.

Asia Deal Watch: Ono Calls On PRISM BioLab’s Capabilities

 
• By Lisa Takagi, Jung Won Shin, Dexter Jie Yan, and Joseph Haas

Plus transactions involving Nissan Chemical/Sanwa Kagaku, Memel/Therabest, Chugai/Alnylam, Takeda/Kumquat, Nxera/Handok, 3SBio/CStone and deals in brief.

Deal Watch: Bristol Adds To Vaccines ‘Repertoire,’ Takes ‘Scenic’ View Of Cellular Pathways

 
• By Joseph Haas

BMS partners with Repertoire and Scenic, plus deals involving: G1/Pepper, Harmony/Epygenix, Biodexa/Emtora, Regeneron/Mammoth, Vertex/Treefrog and Immedica/KKR/Impilo.